https://biography.omicsonline.org/sweden/university-of-california/barabote-ravi-d- https://biography.omicsonline.org/sweden/cerecor/uli-hacksell-1472790

Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships.

Dr. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017. John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim Chief Executive Officer. SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today.

Uli hacksell biography

In his past career he was Chairman at Glionova AB, Biography Hacksell has over 20 years of international R&D management experience from both large pharmaceutical and biotech companies as well as over 10 years of experience as public company CEO. Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to becoming a public multibillion dollar company. Biography. Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since May of 2015. Prior to Cerecor, Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $52,200 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $52,200 and over the last 17 years Uli sold CERC stock worth over $0. STOCKHOLM, JUNE 1, 2015 – Glionova Therapeutics, an oncology-focused biopharmaceutical company today announced that Dr. Uli Hacksell has joined its board of directors as chairman. “It’s our privilege to welcome Dr. Hacksell on our board of directors.” said Eugen Steiner, M.D., Ph.D., Chief Executive Officer of Glionova Therapeutics.

Uli Hacksell ist derzeit Board Member bei Active Biotech, Chairman of the Board bei Adhera Therapeutics und Director (promoted on May 5 2021 to Chairman of the Board) bei Medivir.

McGraw Hill Book Co., NY 1985, pp.25-30. 22 Lyons A.S. and Petrucelli R.J.: Medicine: An Illustrated History. Harry N. Abrams. PHARMACEUTICALS INC., ULI HACKSELL and STEPHEN R. DAVIS, Defendants whose biography says she has briefed Senators on judicial nominations Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships.

2018-10-16

Helena Danielson Ph.D.

Uli Hacksell-,Director, Chief Executive Officer and President-ACADIA Pharmaceuticals Inc,ACADIA Pharmaceuticals Inc The estimated Net Worth of Uli Hacksell is at least $64.2 Tausend dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $64,200 and over the last 17 years Uli sold CERC stock worth over $0. Medivir fokuserar på klinisk utveckling och utser Uli Hacksell till tf vd.
Golden thai tranås

STOCKHOLM, JUNE 1, 2015 – Glionova Therapeutics, an oncology-focused biopharmaceutical company today announced that Dr. Uli Hacksell has joined its board of directors as chairman. “It’s our privilege to welcome Dr. Hacksell on our board of directors.” said Eugen Steiner, M.D., Ph.D., Chief Executive Officer of Glionova Therapeutics. “With his vast experience he will be … Read more 2018-10-16 Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders. “Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Shareholders of SynAct Pharma proposes Uli Hacksell as new board member Tue, Oct 20, 2020 11:42 CET. Shareholders together representing more than 20 per cent of the shares and votes in the company has announced that they propose Uli Hacksell to be elected as new board member of SynAct Pharma.

2021-04-07 · Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och bioteknikbolag, däribland som vd för San Diego-baserade Acadia Pharmaceuticals.
Hjalpmedel for parkinsonpatienter

seiko 2021 catalog
how beautiful it is to find someone who asks for nothing but your company
apollo cypern 2021
ag advokatbyrå allabolag
roland andersson skådespelare
grodprinsen

Uli Hacksell is currently. Board Member - Active Biotech (org chart) Chairman of the Board - Adhera Therapeutics (org chart) Director - Medivir (org chart) Director - InDex Pharmaceuticals (org chart) Create an alert to follow the career of Uli Hacksell.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $62,000 and over the last 17 years Uli … Release Summary. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2014 Earnings Conference Call November 10, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, Investor Relations Uli Hacksell – Chief Uli Hacksell This page shows the track record and history of Hacksell Uli insider trades in ACADIA Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. STOCKHOLM (Nyhetsbyrån Direkt) Uli Hacksell, tidigare vd för och numera styrelseledamot i Medivir, har köpt 52.000 aktier i Medivir för 8:78 kronor styck, motsvarande en totalsumma om nära en halv miljon kronor.

Lehrplan musik grundschule
kreditkostnad bil

About Uli Hacksell, PhD. Dr. Hacksell served as Chief Executive Officer of ACADIA from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery.

Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since May of 2015. Prior to Cerecor, Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., Uli Hacksell. Born: 1950 Title: Member of the Board since 2018. Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. Uli Hacksell.